Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
News by month %2 2018
News by month December 2018
PTCommunity News December 2018
FDA Approves Tolsura for Systemic Fungal Infections
Motegrity Approved for Treatment of Chronic Idiopathic Constipation
FDA Grants 510(k) Clearance for Cardiac Output Device
Herzuma Approved for Treatment of Breast Cancer
Mobile App Helps Patients With Opioid Use Disorder Remain in Recovery
Biosimilar CT-P13 Demonstrates Equivalent Safety and Efficacy in Treatment of Crohn’s Disease
Oxybutynin Reduces Hot Flashes, Improves Breast Cancer Survivor Quality of Life
M7824 Receives Orphan Drug Designation for Biliary Tract Cancer
Xospata Approved for Acute Myeloid Leukemia With FLT3 Mutation
Firdapse Approved for Treatment of Lambert-Eaton Myasthenic Syndrome
Symptoms of Differentiation Syndrome Going Unrecognized with Idhifa
FDA Approves Truxima for Non-Hodgkin’s Lymphoma
Lemtrada Can Cause Serious, But Rare, Risk of Stroke and Tears in Artery Lining
New, One-Time Corticosteroid for Post-Surgical Ocular Pain Approved
